Maternal and fetal adropin levels in gestational diabetes mellitus

References

[1] American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care. 2006;29(Suppl 1):43–8.10.2337/diacare.29.s1.06.s43Search in Google Scholar

[2] Butler AA, Tam CS, Stanhope KL, Wolfe BM, Ali MR, O’Keeffe M, et al. Low circulating adropin concentrations with obesity and aging correlate with risk factors for metabolic disease and increase after gastric bypass surgery in humans. J Clin Endocrinol Metab. 2012;97:3783–91.10.1210/jc.2012-2194Search in Google Scholar PubMed PubMed Central

[3] Farías M, San Martín R, Puebla C, Pearson JD, Casado JF, Pastor-Anglada M, et al. Nitric oxide reduces adenosine transporter ENT1 gene (SLC29A1) promoter activity in human fetal endothelium from gestational diabetes. J Cell Physiol. 2006;208:451–60.10.1002/jcp.20680Search in Google Scholar PubMed

[4] Ganesh Kumar K, Zhang J, Gao S, Rossi J, McGuinness OP, Halem HH, et al. Adropin deficiency is associated with increased adiposity and insulin resistance. Obesity (Silver Spring). 2012;20:1394–402.10.1038/oby.2012.31Search in Google Scholar PubMed PubMed Central

[5] Guzmán-Gutiérrez E, Abarzúa F, Belmar C, Nien JK, Ramírez MA, Arroyo P, et al. Functional link between adenosine and insulin: a hypothesis for fetoplacental vascular endothelial dysfunction in gestational diabetes. Curr Vasc Pharmacol. 2011;9:750–62.10.2174/157016111797484062Search in Google Scholar PubMed

[6] International Association of Diabetes and Pregnancy Study Groups Consensus Panel, Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, Damm P, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33:676–82.10.2337/dc09-1848Search in Google Scholar PubMed PubMed Central

[7] Kaaja RJ, Greer IA. Manifestations of chronic disease during pregnancy. J Am Med Assoc. 2005;294:2751–7.10.1001/jama.294.21.2751Search in Google Scholar PubMed

[8] King H. Epidemiology of glucose intolerance and gestational diabetes in women of childbearing age. Diabetes Care. 1998;21:B9–B13.Search in Google Scholar

[9] Kumar KG, Trevaskis JL, Lam DD, Sutton GM, Koza RA, Chouljenko VN, et al. Identification of adropin as a secreted factor linking dietary macronutrient intake with energy homeostasis and lipid metabolism. Cell Metab. 2008;8:468–81.10.1016/j.cmet.2008.10.011Search in Google Scholar PubMed PubMed Central

[10] Leach L. Placental vascular dysfunction in diabetic pregnancies: intimations of fetal cardiovascular disease? Microcirculation. 2011;18:263–9.10.1111/j.1549-8719.2011.00091.xSearch in Google Scholar PubMed

[11] Lian W, Gu X, Qin Y, Zheng X. Elevated plasma levels of adropin in heart failure patients. Intern Med. 2011;50:1523–7.10.2169/internalmedicine.50.5163Search in Google Scholar PubMed

[12] Lovren F, Pan Y, Quan A, Singh KK, Shukla PC, Gupta M, et al. Adropin is a novel regulator of endothelial function. Circulation. 2010;122:185–92.10.1161/CIRCULATIONAHA.109.931782Search in Google Scholar

[13] Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–9.10.1007/BF00280883Search in Google Scholar

[14] Naylor CD, Sermer M, Chen E, Farine D. Selective screening for gestational diabetes mellitus. N Engl J Med. 1997;337:1591–6.10.1056/NEJM199711273372204Search in Google Scholar

[15] Ozumba BC, Obi SN, Oli JM. Diabetes mellitus in pregnancy in an African population. Int J Gynaecol Obstet. 2004;84:114–9.10.1016/S0020-7292(03)00210-8Search in Google Scholar

[16] Pandolfi A, Di Pietro N. High glucose, nitric oxide, and adenosine: a vicious circle in chronic hyperglycaemia? Cardiovasc Res. 2010;86:9–11.10.1093/cvr/cvq055Search in Google Scholar

[17] Seshiah V, Balaji V, Balaji MS, Sanjeevi CB, Green A. Gestational diabetes mellitus in India. J Assoc Physicians India. 2004;52:707–11.Search in Google Scholar

[18] Sobrevia L, Abarzúa F, Nien JK, Salomón C, Westermeier F, Puebla C, et al. Differential placental macrovascular and microvascular endothelial dysfunction in gestational diabetes. Placenta. 2011;32:159–64.10.1016/j.placenta.2010.12.011Search in Google Scholar

[19] Solomon CG, Willett WC, Carey VJ, Rich-Edwards J, Hunter DJ, Colditz GA, et al. A prospective study of pregravid determinants of gestational diabetes mellitus. J Am Med Assoc. 1997;278:1078–83.10.1001/jama.1997.03550130052036Search in Google Scholar

[20] Torloni MR, Betrán AP, Horta BL, Nakamura MU, Atallah AN, Moron AF, et al. Prepregnancy BMI and the risk of gestational diabetes: a systematic review of the literature with meta-analysis. Obes Rev. 2009;10:194–203.10.1111/j.1467-789X.2008.00541.xSearch in Google Scholar

[21] Westermeier F, Salomón C, González M, Puebla C, Guzmán-Gutiérrez E, Cifuentes F, et al. Insulin restores gestational diabetes mellitus-reduced adenosine transport involving differential expression of insulin receptor isoforms in human umbilical vein endothelium. Diabetes. 2011; 60:1677–87.10.2337/db11-0155Search in Google Scholar

[22] Wolfe HM, Zador IE, Gross TL, Martier SS, Sokol RJ. The clinical utility of maternal body mass index in pregnancy. Am J Obstet Gynecol. 1991;164:1306–10.10.1016/0002-9378(91)90705-VSearch in Google Scholar